February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. – Agenus
Oct 11, 2023, 22:39

Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. – Agenus

Agenus, made the following post on LinkedIn:

Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer.”

For details click here.
Source: Agenus/LinkedIn